The OASAS guidance also directs providers to Drug Enforcement Agency (DEA)guidancethat waives face-to-face, in-person medical evaluation requirements for a patient and DEA-registered or Drug Addiction Treatment Act (DATA)-waived practitioners prior to prescribing controlled substances. Instead, a presc...